“[This] decision from the Supreme Court to uphold the stay on mifepristone allows us to breathe a temporary sigh of relief. As this case goes through the appeals process, millions of people will be able to continue to access mifepristone in states where abortion remains legal,” Rebecca Hart Holder, president of Reproductive Equity Now, said in an emailed statement. “However, we need to be clear-eyed that this is not the end of our battle to protect medication abortion access nationwide. ... Every day that preserves abortion access is a good day, but the fight continues.”

“We should not pretend that ultimately the courts will vindicate our rights,” said Rebecca Hart Holder, head of Reproductive Equity Now. “The Texas case shows what anti-abortion advocates are trying to do is ban abortion in all 50 states, and they will not stop until they achieve that goal.”

Still, some had a sense of trepidation as the larger case moves on. Rebecca Hart Holder, president of Reproductive Equity Now, a Massachusetts-based advocacy group, said it is impossible to read the tea leaves, given the court’s existing decision to overturn Roe vs. Wade and antiabortion groups’ attempts at a national ban on the procedure.

We asked ourselves what we could do as a state to protect people’s reproductive freedom here in Massachusetts. We were ready with a plan of action when the ruling came down on a Friday evening of a holiday weekend.

"With this stockpiled supply of mifepristone, our providers can continue to offer the gold standard of medication abortion care to thousands of people throughout the state, regardless of what a judge in Texas says," said Reproductive Equity Now President Rebecca Hart Holder. "Today, Massachusetts is sending a clear message that we will fight back against attempts to reach across our borders and restrict access to care."

The doses of mifepristone purchased by UMass Amherst are enough "to ensure sufficient coverage in the state for more than one year," according to a statement from Reproductive Equity Now.

Rebecca Hart Holder, executive director of Boston-based Reproductive Equity Now, said Kacsymryk’s ruling “has no basis in science, medicine, or justice.”

“Everything is on the table with our response, quite frankly,” Hart Holder said.

“We need to be very clear-eyed about how devastating this decision could be if it is upheld by the highest” court, said Rebecca Hart Holder, president of Reproductive Equity Now, a Massachusetts-based advocacy group.

Nothing changes for at least the next week, because of the Texas seven-day stay, but “it’s hard to predict what will happen on day eight,” said Rebecca Hart Holder, head of Boston-based Reproductive Equity Now.

The Texas ruling “is playing with our lives in a really disgusting and disingenuous way,” said Hart Holder. “People are not going to know what’s legal, what’s not legal, when they can access and where they can go to access care.”

Reproductive Equity Now, a Boston-based nonprofit organization that advocates for abortion access, said in a statement that medication abortion accounts for nearly 50 percent of abortions in Massachusetts and more than 50 percent of abortions nationwide, and has a 99 percent safety rate.

Massachusetts Governor Maura Healey included critical reproductive health care funds in her FY2023 supplemental budget.